All-Cause and Cardiovascular Mortality following Treatment with Metformin or Glyburide in Patients with Type 2 Diabetes Mellitus.
CONCLUSION: Treatment with glyburide is associated with increased all-cause and cardiovascular mortality in patients with T2DM.
PMID: 28287807 [PubMed - in process]
Source: Archives of Iranian Medicine - Category: Middle East Health Authors: Raee MR, Nargesi AA, Heidari B, Mansournia MA, Larry M, Rabizadeh S, Zarifkar M, Esteghamati A, Nakhjavani M Tags: Arch Iran Med Source Type: research
More News: Accidents | Angiography | Cardiology | Cardiovascular | Coronary Artery Bypass Graft | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Glyburide | Heart | Metformin | Middle East Health | Study